Pharmaceutical Companies Update
Daily updates on drug companies, from the latest company formations and mutually beneficial mergers to the acquisitions by the pharmaceutical industry's giants.
- July 2008 Updates
Alopexx is developing novel products for the treatment and prevention of MRSA and other serious infections.
AMRI is a global company that provides scientific services, products and technologies.
Armgo Pharma is developing small-molecule therapeutics, known as ‘rycals’, which target the ryanodine receptor/calcium release channel for the treatment of cardiac, muscular and neurological disorders.
more - June 2008 Updates
Activus Pharma combines organic chemistry, biological redox measurement and nano-particulation technology for creating new therapies for the control of diseases.
Altheus Therapeutics is identifies and implements pharmaceutical strategies for the treatment of inflammatory bowel disease.
ApopLogic Pharmaceuticals is a biotechnology company focused on the development of compounds for the treatment of cancer.
more - May 2008 Updates
Akebia is a spin-off company from Proctor & Gamble focused on the development of treatments for ischaemia and improvement of vascular disease.
Alfama is a pharmaceutical company dedicated to the development of small-molecule drugs to combat inflammation-related diseases.
Alize Pharma is a group of privately-held biopharmaceuticals specializing in the development of therapeutics for metabolic diseases and cancer.
more - April 2008 Updates
Arno Therapeutics is developing innovative anticancers.
Airmid is a virtual pharmaceutical company focused on the development and commercialization of treatments for autoimmune disorders, concerned with the Kv1.3 potassium channel.
AKL International develops drugs derived from botanical sources.
more - March 2008 Updates
Advanced Cancer Therapeutics is a pharmaceutical company focused on the discovery and early development of cancer therapeutics.
Privately-owned Alphamed Pharmaceuticals is engaged in the development of prescription and over-the-counter products for human and animal use.
more - February 2008 Updates
Beijing Mefuvir Medicinal Technology conducts the pharmaceutical business of its Chinese parent company Wuhun Humanwell Hi-tech Industry.
Biovascular is a biotechnology company developing drugs and devices for the control of intimal hyperplasia.
more - January 2008 Updates
Anza Therapeutics is a company formed around the spin-off of Cerus' immunotherapy assets, which include Listeria and KBMA platform technologies.
Derma Sciences is a fully-integrated manufacturer, marketer and supplier of a complete line of products for wound and skin care.
more - December 2007 Updates
Clarus Therapeutics is dedicated to the development and commercialization of androgen-based therapeutics.
Inspiration Therapeutics is engaged in the development of innovative blood recombinant blood coagulation factor products to fundamentally change the treatment of hemophilia.
more - November 2007 Updates
Aquinox Pharmaceuticals is interested in the development and commercialisation of novel and targeted small molecules for the treatment of cancer and inflammatory disease.
AlloCure is focused on the development of stem cell therapies for the treatment of various indications.
more - October 2007 Updates
Bio-Ker is developing biosimilars, recombinant proteins, controlled-delivery systems and therapeutic plasmid DNA vaccines.
CG Therapeutics is a biotechnology company developing cancer therapeutics focused on inhibiting hCG
more - September 2007 Updates
Norwegian company, Bio-Medisinsk Innovasjon develops drugs based on compounds that interfere with serotonin.
DiaMedica is developing treatments for all stages of Type II diabetes, by repostioning existing drugs and developing NCEs.
more - August 2007 Updates
AB Science is a French company developing an anticancer drug.
Akela Pharma focuses on the development of inhalation treatments for pain and CNS disorders.
Privately-owned Alacrity Biosciences is focused on the development of treatments for ocular surface diseases, retinal diseases and glaucoma.
more - July 2007 Updates
Advancis Pharmaceuticals has changed its name to MiddleBrook Pharmaceuticals.
Alteon has acquired Israeli Company HaptoGuard.
Amgen has acquired Iilypsa, a private company developing non-absorbed drugs for renal disorders.
more - June 2007 Updates
Coronado Biosciences is engaged in developing novel and proprietary cancer therapeutics.
Pfizer has acquired privately-owned biopharmaceutical company BioRexis.
more - May 2007 Updates
Autoimmune focussed company, The Immune Response Corporation has changed its name to Orchestra Therapeutics.
Metabolic Research develops non-synthetic compounds for the treatment of arthritis, heart disease, metabolic and inflammatory diseases and cancer.
more - April 2007 Updates
Biogen Idec has acquired the biopharmaceutical company Syntonix, which remains as a wholly-owned subsidiary.
Biopharmaceutical company Endotis Pharma operates in the field of therapeutic glyomics and is investigating the use of oligosaccharide-based drugs in the fields of oncology and thrombosis.
more - March 2007 Updates
US giant Eli Lilly has acquired ICOS, which will remain a wholly-owned subsidiary.
OBEcure is an Israeli drug discovery company, focused on the development of antiobesity therapies.
more - February 2007 Updates
Merck KGaA has taken over Serono, which will become a subsidiary under the name Merck Serono
CoDa Therapeutics is developing novel wound healing products based on gap junction modulation.
more - January 2007 Updates
Crucell has acquired Stockholm-based SBL Vaccin AB
BioProgress is using its proprietary polymer technology to develop and enhance its own pharmaceutical products and those of its partners.
more - December 2006 Updates
Amgen latest acquisition is Avidia
Amorcyte is a therapeutics company pursuing cellbased therapies for cardiovascular diseases.
more - October 2006 Updates
Athenagen and Zapaq have merged to form a neurology-focused company, Athenagen
Axordia is a UK-based human embryonic stem cell company.
more
